Rossby Financial’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
Other funds holding RARE
Rossby Financial's RARE Position: Q3 2026 in Review
Rossby Financial reduced its Ultragenyx Pharmaceutical (RARE) stake by 50% in Q3 2026, selling an estimated $480 and leaving 20 shares worth $301. The position accounts for ﹤0.01% of the portfolio, ranked #2402.
Rossby Financial first reported a position in RARE in Q1 2026 and has held it in 3 quarters since. The position peaked at $1.34K in Q2 2026. 268 funds tracked by Wall St. Rank hold RARE as of Q3 2026.
- Rossby Financial held 20 shares of Ultragenyx Pharmaceutical worth $301 as of Q3 2026.
- Rossby Financial sold 20 Ultragenyx Pharmaceutical shares in Q3 2026, an estimated $480.
- Ultragenyx Pharmaceutical made up ﹤0.01% of Rossby Financial's portfolio in Q3 2026, its #2402 holding.
- Rossby Financial first reported a position in Ultragenyx Pharmaceutical in Q1 2026 and has held it in 3 quarters since.
- Rossby Financial's Ultragenyx Pharmaceutical position peaked at $1.34K in Q2 2026.
- 268 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q3 2026.
Based on Rossby Financial's 13F filing for Q3 2026, filed 5 Nov 2026.